HP and 3Com Corporation (NASDAQ: COMS) (“3Com”) announced that they have entered into a definitive agreement under which HP will purchase 3Com, a leading provider of networking switching, routing and security solutions, at a price of $7.90 per share in cash or an enterprise value of approximately $2.7 billion.
The Tourism and Culture Minister Smt. Ambika Soni has stressed the need to promote India as the new emerging Medical Value Travel destination abroad. She was speaking at the 4th India Health Summit here. Smt. Soni said the way medial tourism has developed in recent times is largely linked to economics and technology and India is positioning itself as the primary medical destination for the most complex medical procedures in the world.
Orthopedic researchers at Jefferson Medical College have for the first time found stem cells in the intervertebral discs of the human spine, suggesting that such cells might someday be used to help repair degenerating discs and remedy lower back and neck pain.
Homoeopathy is a science of Life. Human beings are liable to various kinds of diseases though the creator has created them to be healthy; but, there are different kinds of circumstances, temptations and pitfalls which affect the human beings on physical as well as on mental levels. The mode living, eating habits, atmospheric change, mental stress and also the telluric effects are the factors singly or in combination which affect the health of individuals.
University of Cincinnati (UC) radiologists have developed a new technique for capturing images of chest veins that eases diagnosis of venous diseases.
Massachusetts General Hospital (MGH) researchers have a developed a totally new approach to treating liver failure – manipulating the immune response. If the results of the animal study can be applied in human patients, the approach may be able to keep patients alive until donor organs become available or to support liver function until the organ can regenerate itself, eliminating the need for a transplant.
GlaxoSmithKline (GSK) announced that the European Commission has granted a marketing authorisation for its cervical cancer vaccine, Cervarix for all 27 European member states.
Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.